【レポートの概要（一部）】
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Value chain analysis
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market outlook
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• On-body wearable injectors – Market size and forecast 2019-2024
• Off-body wearable injectors – Market size and forecast 2019-2024
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Technological advancements in wearable injectors
• Increasing number of partnerships and collaborations
• Increasing focus on development of biologics
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Amgen Inc.
• Becton, Dickinson and Co.
• Enable Injections Inc.
• Gerresheimer AG
• Insulet Corp.
• Medtronic Plc
• Tandem Diabetes Care Inc.
• Valeritas Inc.
• West Pharmaceutical Services Inc.
• Ypsomed AG
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Global healthcare supplies market
Exhibit 02: Segments of global healthcare supplies market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Product overview
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Product – Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: On-body wearable injectors – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: On-body wearable injectors – Year-over-year growth 2020-2024 (%)
Exhibit 22: Off-body wearable injectors – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Off-body wearable injectors – Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America – Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Product launch details and market impact analysis
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Amgen Inc. – Vendor overview
Exhibit 46: Amgen Inc. – Business segments
Exhibit 47: Amgen Inc. – Organizational developments
Exhibit 48: Amgen Inc. – Geographic focus
Exhibit 49: Amgen Inc. – Key offerings
Exhibit 50: Amgen Inc. – Key customers
Exhibit 51: Becton, Dickinson and Co. – Vendor overview
Exhibit 52: Becton, Dickinson and Co. – Product segments
Exhibit 53: Becton, Dickinson and Co. – Organizational developments
Exhibit 54: Becton, Dickinson and Co. – Geographic focus
Exhibit 55: Becton, Dickinson and Co. – Segment focus
Exhibit 56: Becton, Dickinson and Co. – Key offerings
Exhibit 57: Becton, Dickinson and Co. – Key customers
Exhibit 58: Enable Injections Inc. – Vendor overview
Exhibit 59: Enable Injections Inc. – Product segments
Exhibit 60: Enable Injections Inc. – Organizational developments
Exhibit 61: Enable Injections Inc. – Key offerings
Exhibit 62: Enable Injections Inc. – Key customers
Exhibit 63: Gerresheimer AG – Vendor overview
Exhibit 64: Gerresheimer AG – Business segments
Exhibit 65: Gerresheimer AG – Organizational developments
Exhibit 66: Gerresheimer AG – Geographic focus
Exhibit 67: Gerresheimer AG – Segment focus
Exhibit 68: Gerresheimer AG – Key offerings
Exhibit 69: Gerresheimer AG – Key customers
Exhibit 70: Insulet Corp. – Vendor overview
Exhibit 71: Insulet Corp. – Business segments
Exhibit 72: Insulet Corp. – Organizational developments
Exhibit 73: Insulet Corp. – Geographic focus
Exhibit 74: Insulet Corp. – Key offerings
Exhibit 75: Insulet Corp. – Key customers
Exhibit 76: Medtronic Plc – Vendor overview
Exhibit 77: Medtronic Plc – Business segments
Exhibit 78: Medtronic Plc – Organizational developments
Exhibit 79: Medtronic Plc – Segment focus
Exhibit 80: Medtronic Plc – Key offerings
Exhibit 81: Medtronic Plc – Key customers
Exhibit 82: Tandem Diabetes Care Inc. – Vendor overview
Exhibit 83: Tandem Diabetes Care Inc. – Business segments
Exhibit 84: Tandem Diabetes Care Inc. – Organizational developments
Exhibit 85: Tandem Diabetes Care Inc. – Key offerings
Exhibit 86: Tandem Diabetes Care Inc. – Key customers
Exhibit 87: Valeritas Inc. – Vendor overview
Exhibit 88: Valeritas Inc. – Business segments
Exhibit 89: Valeritas Inc. – Organizational developments
Exhibit 90: Valeritas Inc. – Key offerings
Exhibit 91: Valeritas Inc. – Key customers
Exhibit 92: West Pharmaceutical Services Inc. – Vendor overview
Exhibit 93: West Pharmaceutical Services Inc. – Business segments
Exhibit 94: West Pharmaceutical Services Inc. – Organizational developments
Exhibit 95: West Pharmaceutical Services Inc. – Geographic focus
Exhibit 96: West Pharmaceutical Services Inc. – Segment focus
Exhibit 97: West Pharmaceutical Services Inc. – Key offerings
Exhibit 98: West Pharmaceutical Services Inc. – Key customers
Exhibit 99: Ypsomed AG – Vendor overview
Exhibit 100: Ypsomed AG – Business segments
Exhibit 101: Ypsomed AG – Organizational developments
Exhibit 102: Ypsomed AG – Geographic focus
Exhibit 103: Ypsomed AG – Segment focus
Exhibit 104: Ypsomed AG – Key offerings
Exhibit 105: Ypsomed AG – Key customers
Exhibit 106: Validation techniques employed for market sizing
Exhibit 107: Definition of market positioning of vendors
【レポート販売概要】
■ タイトル：ウェアラブルインジェクターの世界市場予測・分析2020-2024■ 英文：Wearable Injectors Market by Product and Geography - Forecast and Analysis 2020-2024
■ 発行日：2019年11月26日
■ 調査会社：Technavio
■ 商品コード：IRTNTR40104
■ 調査対象地域：グローバル
- 世界のリアルタイム入札ベース広告ディスプレイ市場動向（2012-2016）TechNavio's analysts forecast the Global Real-time Bidding-based Ad Display market to grow at a CAGR of 43.8 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need for improved return on investment. The Global Real-time Bidding-based Ad Display market has also been witnessing increasing demand for RTB-based direct display ad sales. However, data le …
- ハエ駆除用化学薬品の世界市場：種類別（殺幼虫剤＆殺ダニ剤）、廃棄物処理方法別（機械的生物学的処理、焼却、嫌気性消化）、適用方法別（毒性餌、ジクロロス気化器、屋外噴霧、殺幼虫剤噴霧器、その他）The fly control chemicals market for waste management accounted for $74.4 billion in 2018 and is anticipated to reach $120.9 billion by 2026, registering a CAGR of 6.1% from 2019 to 2026. Waste management is a systematic procedure of treating waste, comprising numerous activities such as collecting, transportation, and treatment (mechanical/ biological/ chemical). The growth of the market is drive …
- 世界の波長分割マルチプレクサ市場2015The Global Wavelength Division Multiplexer Industry Report 2015 is a professional and in-depth study on the current state of the Wavelength Division Multiplexer industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Wavelength Division Multiplexer market analysis is provided for the international markets …
- 世界の化学発泡剤市場2015The Global Chemical Blowing Agents Industry Report 2015 is a professional and in-depth study on the current state of the Chemical Blowing Agents industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Chemical Blowing Agents market analysis is provided for the international markets including development t …
- 光干渉断層画像診断法（OTC）の世界市場2017-2021About OCT OCT can help to identify diseases such as diabetic retinopathy and glaucoma at the granular level by providing the images of the retina in layers, which can help physicians identify the disease and form a treatment plan. Technavio’s analysts forecast the global OCT market to grow at a CAGR of 8.16% during the period 2017-2021. [Covered in this report] The report covers the present scenar …
- インドの心臓律動管理（CRM）装置市場見通しIndia Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 Summary GlobalData’s new report, "India Cardiac Rhythm Management (CRM) Procedures Outlook to 2021", provides key procedures data on the India Cardiac Rhythm Management (CRM) Procedures. The report provides procedure volumes within market segments - Implantable Loop Recorder (ILR) Procedures, Cardiac Resynchronisation Therapy (CRT) P …
- フォトニック集積回路（IC）の世界市場分析：コンポーネント別（レーザー、MUX / DEMUX、光増幅器、変調器、減衰器、および検出器）、集積別（モノリシック、ハイブリッド、およびモジュール）、原材料別（インジウム・リン、シリコン・オン・シリコン、シリコン、ガリウムヒ素その他）、用途別（光通信、センシング、バイオフォトニクス、光信号処理）、セグメント予測The photonic IC market is expected to reach USD 3.54 billion by 2024 according to a new report by Grand View Research, Inc. Photonic IC is an integrated circuit that uses optical wavelength as an information signal and provides multiple integrated photonic functions. Photonic IC, as such, is similar to an electronic IC and can be a viable replacement for it as well as for the copper-based wired tr …
- Sinusitis：グローバル臨床試験レビューH2, 2013Sinusitis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Sinusitis Global Clinical Trials Review, H2, 2013" provides data on the Sinusitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sinusitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial c …
- Victoria Oil & Gas plc：石油・ガスの開発・生産動向及びコスト分析– 2012Victoria Oil & Gas plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Victoria Oil & Gas plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
- 末梢動脈閉塞性疾患(Peripheral Artery Occlusive Disease (PAOD))：治療薬開発パイプライン動向（2015年上半期版）Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015’, provides an overview of the Peripheral Artery Occlusive Disease (PAOD)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Peripheral Artery Occlusive Disease (PAOD), com …
- 1,3-ジクロロプロペンの世界市場1,3-dichloropropene (CAS 542-75-6) Market Research Report 2013 presents comprehensive data on 1,3-dichloropropene markets globally and regionally (Europe, Asia, North America etc.) The 1,3-dichloropropene (CAS 542-75-6) Market Research Report 2013 includes 1,3-dichloropropene description, covers its application areas and related patterns. It overviews 1,3-dichloropropene market, names 1,3-dichloro …
- Familial Chylomicronemia (Type I Hyperlipoproteinemia)：治療薬のグローバル治験動向（2014年上半期）Familial Chylomicronemia (Type I Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Familial Chylomicronemia (Type I Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2014" provides data on the Familial Chylomicronemia (Type I Hyperlipoproteinemia) clinical trial scenario. This report provides elemental information and data relating to …
- 企業向けLMS（学習管理システム）の世界市場2017-2021About Corporate LMS LMS are software applications that are used to plan, deliver, and manage learning process. They use web-based technology to manage, administer, track, and report on the delivery of content, and evaluate the performance of participants. A large number of corporates are widely adopting these solutions due to the substantial cost benefits and proven results of increased efficiency …
- メキシコの気道装置・麻酔装置市場Mexico Airway and Anesthesia Devices Market Outlook to 2021 Summary GlobalData’s new report, "Mexico Airway and Anesthesia Devices Market Outlook to 2021", provides key market data on the Mexico Airway and Anesthesia market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Anesthesia Circuits, Anesthesia Masks, …
- 心臓発作：治療薬のグローバル治験動向（2014年下半期）Heart Attack Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Heart Attack Global Clinical Trials Review, H2, 2014" provides data on the Heart Attack clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Heart Attack. It includes an overview of the trial numbers and their recruitment status as per the sit …
